Clinical Trial Update: Bipolar Study in Adults at Least 18 Years of Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for bipolar disorder in adults 18 and older; the study sponsored by GlaxoSmithKline has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED